Dr. Stephen E. Rubenstein

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Theresa Mchugh is a Hematologist Oncology specialist and a Hematologist in Wynewood, Pennsylvania. Dr. Mchugh is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, D-Plus Hemolytic Uremic Syndrome, and Hemolytic-Uremic Syndrome.

Pallavi Rastogi is an Oncologist and a Hematologist in Paoli, Pennsylvania. Dr. Rastogi is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Paget Disease of the Breast, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.